While it is preferable initially to perform haplotype analysis in multigeneration families, for sporadic cases or small families it is often unhelpful. Here we describe a COL5A2 mutation in a small family which showed the clinical phenotype of EDS II (NPB). Electron microscopic analysis of dermal collagen structure in this family showed only minor variability in the collagen fibril size and shape (data not shown). Cultured skin fibroblasts were labelled with '4C proline and the collagens synthesised were analysed by SDS polyacrylamide gel electrophoresis (fig 1) . Type V collagen from the cell line migrated more slowly than that from a control. Similar observations have been made in cases of osteogenesis imperfecta where mutations in either COLlAl or COL1A2 cause overmodification of both al (I) and a2(I) collagen proteins.2' Thus, in this case it was COL5A1
While it is preferable initially to perform haplotype analysis in multigeneration families, for sporadic cases or small families it is often unhelpful. Here we describe a COL5A2 mutation in a small family which showed the clinical phenotype of EDS II (NPB). Electron microscopic analysis of dermal collagen structure in this family showed only minor variability in the collagen fibril size and shape (data not shown). Cultured skin fibroblasts were labelled with '4C proline and the collagens synthesised were analysed by SDS polyacrylamide gel electrophoresis (fig 1) . Type V collagen from the cell line migrated more slowly than that from a control. Similar likely that there was a mutation in either COL5A1 or COL5A2. Haplotype analysis was undertaken using markers (COL5A1, D9S1818, COL3A1, and D2S389) within or close to either COL5A1 or COL5A2.8 [22] [23] [24] [25] The haplotypes (fig 2) excluded COLMAM, but were concordant with COL5A2 as the disease locus. While the family was too small to generate a significant lod score, the combination of protein profile with haplotype analysis strongly implied a causative mutation in COL5A2. The cDNA for the complete coding sequence of a2(V) collagen (accession NoY14690) was reverse transcribed and amplified from RNA as 11 overlapping products. Each of these were directly sequenced. A single base mutation was seen, which converted an obligatory glycine within the triple helical region of the molecule to arginine (fig 3) . This change was confirmed in each affected family member by amplification and sequencing (fig 3) of a 500 bp genomic DNA product. Each affected subject contained the same G to C base change (data are only shown for III.2), and an intron was positioned between bases 3600 and 3601 of the cDNA sequence (fig 3) . The mutation abolished a BsrI restriction enzyme site which normally removed 80 bp from one end of the 500 bp product. Incubation of the amplified genomic DNA with this enzyme confirmed the sequencing results ( fig 4) and that this change was absent in 50 chromosomes from 25 unrelated controls.
This alteration is typical of many mutations in other fibrillar collagens which cause inherited disorders, such as osteogenesis imperfecta, the chondrodysplasias, and EDS type IV. 26 This, along with the absence of this change in normal subjects, provides strong evidence that it is the causative mutation in this EDS II family. Only a few mutations of COLMAM and We would like to thank Mr M P Snead for ophthalmic examination of the proband and Mrs M Laidlaw for assistance with tissue culture. NPB was supported by a grant from the Wellcome Trust (044116).
